US Patent 8092799 Antibodies to Apo-2 receptor polypeptides
Patent 8092799 was granted and assigned to Genentech on January, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+219 characters)
Article
Patent abstract
Novel polypeptides, designated Apo-2, which are capable of modulating apoptosis are provided. Compositions including Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 are also provided.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Anan Chuntharapai0
Avi J Ashkenazi0
Camellia W Adams0
Kyung Jin Kim0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08092799 Antibodies to Apo-2 receptor polypeptides US Patent 8092799 Antibodies to Apo-2 receptor polypeptides
Infobox
Patent Number
080927990
Patent Number
80927990
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080927990
Date of Patent
January 10, 2012
0Patent Application Number
128594360
Date Filed
August 19, 2010
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08092799 Antibodies to Apo-2 receptor polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08092799
Date of patent
January 10, 2012
Patent application number
12859436
Date Filed
August 19, 2010
Patent primary examiner
Find more entities like US Patent 8092799 Antibodies to Apo-2 receptor polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
